Lavomax pills 125mg №10

Indications

The drug is used in adults as part of complex therapy:

- viral hepatitis A, B and C;

- herpes infection;

- cytomegalovirus infection;

- infectious-allergic and viral encephalomyelitis;

- urogenital and respiratory chlamydia;

- non-gonococcal urethritis;

- pulmonary tuberculosis.

Treatment and prevention of influenza and other acute respiratory viral infections.

Dosage and administration

The drug is taken orally after meals.

At treatment of influenza and other acute respiratory viral infections - in the first two days of the disease - 125 mg, then - every other day, 125 mg. Course dose - 750 mg (for the course of treatment - 6 tab. 125 mg each).

For prevention of influenza and other acute respiratory viral infections - 125 mg once a week for 6 weeks. For the course of treatment - 6 tab. 125 mg.

For treatment of viral hepatitis A - the first day 125 mg 2 times, then 125 mg every other day. Heading dose - 1.25 g (per course of treatment - 10 tab. 125 mg each).

For treatment of acute hepatitis B - the first and second days for 125 mg, then - for 125 mg every other day. The course dose - 2 g (for the course of treatment - 16 tab. 125 mg each), with a protracted course of hepatitis B - 125 mg 2 times / day on the first day, then - 125 mg every other day. The course dose is 2.5 g (for the course of treatment - 20 tab. 125 mg each).

At chronic hepatitis B - the initial phase of treatment (2.5 g) - the first two days at 250 mg, then - at 125 mg every other day. The continuation phase (from 1.25 g to 2.5 g) is 125 mg per week.Course dose drug Lavomaks^® from 3.75 to 5 g (for a course of treatment - from 30 to 40 tab. 125 mg each), the duration of therapy is 3.5-6 months depending on the results of biochemical, immunological, morphological studies, reflecting the degree of activity of the process.

At acute hepatitis C - the first and second days for 125 mg, then - for 125 mg every other day. Course dose - 2.5 g (per course of treatment - 20 tab. 125 mg each).

At chronic hepatitis C - the initial phase of treatment (2.5 g) - the first two days at 250 mg, then - 125 mg every other day. The continuation phase (2.5 g) - 125 mg per week. Course dose drug Lavomaks^® - 5 g (per course of treatment - 40 tab. 125 mg each). The duration of therapy is 6 months, depending on the results of biochemical, immunological, morphological markers of the process activity.

For treatment of herpes, cytomegalovirus infection - the first two days, 125 mg, then - every other day, 125 mg. Course dose - 2.5 g (per course of treatment - 20 tab. 125 mg each).

At urogenital and respiratory chlamydia, non-gonococcal urethritis - the first two days, 125 mg, then - every other day, 125 mg. Heading dose - 1.25 g (per course of treatment - 10 tab. 125 mg each).

AT composition of complex therapy of pulmonary tuberculosis - the first two days at 250 mg, then - at 125 mg every other day. Course dose - 2.5 g (per course of treatment - 20 tab. 125 mg each).

AT the composition of the complex therapy of neurovirus infections the dose is set individually, the course of treatment is 4 weeks.

Adverse effects

Possible: short-term chills, allergic reactions, dyspepsia symptoms.

Contraindications

- pregnancy;

- lactation period (breastfeeding);

- children's and teenage age up to 18 years;

- deficiency of sucrase / isomaltase, fructose intolerance, glucose-galactose malabsorption (the product contains sucrose);

- hypersensitivity to the drug.

Use during pregnancy and lactation

Lavamax^® contraindicated for use during pregnancy and lactation (breastfeeding).

Use in children

Contraindicated in children and adolescents under 18 years of age.

Special notes

Influence on ability to drive motor transport and control mechanisms

The use of the drug does not affect the ability to drive vehicles and other potentially hazardous activities that require high concentration of attention and psychomotor reactions.

Overdosage

Cases of drug overdose Lavomax ^® unknown.

Drug interaction

Clinically significant drug interaction Lavomax^® with antibiotics, standard treatment of viral and bacterial diseases, alcohol was not detected.

Compatible with antibiotics and standard treatment of viral and bacterial diseases.

Pharmacy sales terms

The drug is approved for use as a means of OTC.

Terms and conditions of storage

The drug should be stored out of the reach of children, dry, protected from light, at a temperature not exceeding 25 ° C.